HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Os, R. Articles by de Haan, G. Search for Related Content PubMed PubMed Citation Articles by van Os, R. Articles by de Haan, G.

Stem Cell Assays: Something Old, Something New, Something Borrowed

Department of Stem Cell Biology, University of Groningen, The Netherlands

Key Words. Stem cells • Competitive repopulation • Competitor • Reconstitution • Assay

Correspondence: Ronald van Os, Ph.D., Department of Stem Cell Biology, University of Groningen, A. Deusinglaan 1, NL-9713 AV Groningen, The Netherlands. Telephone: 31-50-363-2722; Fax: 31-50-363-7477; e-mail: r.p.van.os{at}med.rug.nl

Numerous assays exist that measure the function of stem cells. In this article, we review in detail the history and future of existing stem cell assays. Hematopoietic stem cells (HSCs) are historically the most well studied, but new developments in stem cell research, including the claim of stem cell plasticity, have caused controversies related to technical issues, as well as to semantics. Stem cell research requires proper definitions, and utilization of stem cell assays, especially since research on non-HSCs that lack solid stem cell assays, is rapidly evolving. These emerging fields may benefit from what has been learned from HSC assays: most important, that the true potential of stem cells can only be assessed retrospectively. This also relates to new developments in HSC research, when limiting numbers of in vitro–manipulated stem cells are transplanted. The most conflicting results arise when cells express stem cell characteristics in one assay but not in another. Should we adjust our definition of a stem cell? If so, when do we decide a claim of stem cell activity to be justified? We therefore recommend using multiple stem cell assays, preferably at least one in vivo assay. These assays should measure functionality of the putative stem cell population.

This article has been cited by other articles:

				R. K. Burt, Y. Loh, W. Pearce, N. Beohar, W. G. Barr, R. Craig, Y. Wen, J. A. Rapp, and J. Kessler Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases JAMA, February 27, 2008; 299(8): 925 - 936. [Abstract] [Full Text] [PDF]

				C.E. Gargett Uterine stem cells: What is the evidence? Hum. Reprod. Update, January 1, 2007; 13(1): 87 - 101. [Abstract] [Full Text] [PDF]

				P. G. Robey and P. Bianco The use of adult stem cells in rebuilding the human face. J Am Dent Assoc, July 1, 2006; 137(7): 961 - 972. [Abstract] [Full Text] [PDF]

				L. M. Kamminga and G. de Haan Cellular Memory and Hematopoietic Stem Cell Aging Stem Cells, May 1, 2006; 24(5): 1143 - 1149. [Abstract] [Full Text] [PDF]